SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'A80'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1CBR_A_REAA200_1 (CELLULAR RETINOIC ACID BINDING PROTEIN TYPE I)	2cbr	PROTEIN (CRABP-I) (Bos taurus)	6 / 12	LEU A 28 ALA A 32 ALA A 35 THR A 54 THR A 56 ARG A 59	A80 A 201 ( 4.0A) A80 A 201 ( 4.1A) A80 A 201 ( 4.1A) A80 A 201 (-3.5A) A80 A 201 (-3.3A) A80 A 201 (-4.8A)	1.37A	1cbrA-2cbrA: 27.2	1cbrA-2cbrA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1CBR_A_REAA200_1 (CELLULAR RETINOIC ACID BINDING PROTEIN TYPE I)	2cbr	PROTEIN (CRABP-I) (Bos taurus)	12 / 12	PHE A 15 LEU A 28 ALA A 32 ALA A 36 PRO A 39 THR A 54 THR A 56 VAL A 58 ARG A 59 LEU A 120 ARG A 131 TYR A 133	None A80 A 201 ( 4.0A) A80 A 201 ( 4.1A) A80 A 201 ( 4.0A) A80 A 201 ( 4.9A) A80 A 201 (-3.5A) A80 A 201 (-3.3A) None A80 A 201 (-4.8A) None A80 A 201 (-3.8A) A80 A 201 (-4.7A)	0.43A	1cbrA-2cbrA: 27.2	1cbrA-2cbrA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1CBR_B_REAB200_1 (CELLULAR RETINOIC ACID BINDING PROTEIN TYPE I)	2cbr	PROTEIN (CRABP-I) (Bos taurus)	6 / 12	LEU A 28 ALA A 32 ALA A 35 THR A 54 THR A 56 ARG A 59	A80 A 201 ( 4.0A) A80 A 201 ( 4.1A) A80 A 201 ( 4.1A) A80 A 201 (-3.5A) A80 A 201 (-3.3A) A80 A 201 (-4.8A)	1.37A	1cbrB-2cbrA: 27.3	1cbrB-2cbrA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1CBR_B_REAB200_1 (CELLULAR RETINOIC ACID BINDING PROTEIN TYPE I)	2cbr	PROTEIN (CRABP-I) (Bos taurus)	12 / 12	PHE A 15 LEU A 28 ALA A 32 ALA A 36 PRO A 39 THR A 54 THR A 56 VAL A 58 ARG A 59 LEU A 120 ARG A 131 TYR A 133	None A80 A 201 ( 4.0A) A80 A 201 ( 4.1A) A80 A 201 ( 4.0A) A80 A 201 ( 4.9A) A80 A 201 (-3.5A) A80 A 201 (-3.3A) None A80 A 201 (-4.8A) None A80 A 201 (-3.8A) A80 A 201 (-4.7A)	0.43A	1cbrB-2cbrA: 27.3	1cbrB-2cbrA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1CBS_A_REAA200_1 (CELLULAR RETINOIC ACID BINDING PROTEIN TYPE II)	2cbr	PROTEIN (CRABP-I) (Bos taurus)	11 / 12	PHE A 15 LEU A 19 ALA A 32 ALA A 36 PRO A 39 THR A 54 THR A 56 VAL A 58 LEU A 120 ARG A 131 TYR A 133	None None A80 A 201 ( 4.1A) A80 A 201 ( 4.0A) A80 A 201 ( 4.9A) A80 A 201 (-3.5A) A80 A 201 (-3.3A) None None A80 A 201 (-3.8A) A80 A 201 (-4.7A)	0.45A	1cbsA-2cbrA: 26.6	1cbsA-2cbrA: 76.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1CBS_A_REAA200_1 (CELLULAR RETINOIC ACID BINDING PROTEIN TYPE II)	2cbr	PROTEIN (CRABP-I) (Bos taurus)	5 / 12	PHE A 15 LEU A 19 ALA A 32 THR A 61 VAL A 58	None None A80 A 201 ( 4.1A) None None	0.91A	1cbsA-2cbrA: 26.6	1cbsA-2cbrA: 76.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1CRB_A_RTLA200_0 (CELLULAR RETINOL BINDING PROTEIN)	2cbr	PROTEIN (CRABP-I) (Bos taurus)	5 / 12	LEU A 19 ALA A 32 ILE A 63 THR A 61 TRP A 109	None A80 A 201 ( 4.1A) None None None	0.89A	1crbA-2cbrA: 15.7	1crbA-2cbrA: 42.14
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1CRB_A_RTLA200_0 (CELLULAR RETINOL BINDING PROTEIN)	2cbr	PROTEIN (CRABP-I) (Bos taurus)	5 / 12	PHE A 15 ALA A 32 ILE A 52 THR A 54 TRP A 109	None A80 A 201 ( 4.1A) None A80 A 201 (-3.5A) None	0.82A	1crbA-2cbrA: 15.7	1crbA-2cbrA: 42.14
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1CRB_A_RTLA200_0 (CELLULAR RETINOL BINDING PROTEIN)	2cbr	PROTEIN (CRABP-I) (Bos taurus)	5 / 12	PHE A 15 LEU A 19 ALA A 32 ILE A 52 TRP A 109	None None A80 A 201 ( 4.1A) None None	0.94A	1crbA-2cbrA: 15.7	1crbA-2cbrA: 42.14
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1CRB_A_RTLA200_0 (CELLULAR RETINOL BINDING PROTEIN)	2cbr	PROTEIN (CRABP-I) (Bos taurus)	5 / 12	PHE A 15 LEU A 19 ALA A 32 ILE A 63 TRP A 109	None None A80 A 201 ( 4.1A) None None	0.90A	1crbA-2cbrA: 15.7	1crbA-2cbrA: 42.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1DED_B_QPSB1501_1 (CYCLODEXTRIN GLUCANOTRANSFERASE)	3gbd	SUCROSE ISOMERASE SMUA FROM PROTAMINOBACTER RUBRUM (Serratia plymuthica)	7 / 12	TYR A 78 ARG A 212 ASP A 214 GLU A 268 HIS A 341 ASP A 342 ARG A 433	EDO A8003 ( 4.4A) None EDO A8003 ( 2.7A) EDO A8001 (-3.1A) None EDO A8002 ( 3.5A) None	0.80A	1dedB-3gbdA: 27.0	1dedB-3gbdA: 26.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1MX8_A_RTLA135_0 (CELLULAR RETINOL-BINDING PROTEIN I, HOLO)	2cbr	PROTEIN (CRABP-I) (Bos taurus)	5 / 12	PHE A 15 LEU A 19 ALA A 32 THR A 61 PHE A 71	None None A80 A 201 ( 4.1A) None None	0.87A	1mx8A-2cbrA: 16.7	1mx8A-2cbrA: 42.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1MXD_A_ACRA735_1 (ALPHA AMYLASE)	3gbd	SUCROSE ISOMERASE SMUA FROM PROTAMINOBACTER RUBRUM (Serratia plymuthica)	8 / 12	TYR A 78 HIS A 118 PHE A 178 ARG A 212 ASP A 214 GLU A 268 HIS A 341 ASP A 342	EDO A8003 ( 4.4A) EDO A8003 (-4.8A) EDO A8003 ( 3.9A) None EDO A8003 ( 2.7A) EDO A8001 (-3.1A) None EDO A8002 ( 3.5A)	0.98A	1mxdA-3gbdA: 22.3	1mxdA-3gbdA: 23.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1QKN_A_RALA600_2 (ESTROGEN RECEPTOR BETA)	3q3q	ALKALINE PHOSPHATASE (Sphingomonas sp. BSAR-1)	3 / 3	ASP A 399 LEU A 469 HIS A 346	None GOL A8002 ( 4.8A) ZN A1559 ( 3.2A)	0.59A	1qknA-3q3qA: undetectable	1qknA-3q3qA: 17.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1TDN_A_LEUA487_0 (L-AMINO ACID OXIDASE)	3gbd	SUCROSE ISOMERASE SMUA FROM PROTAMINOBACTER RUBRUM (Serratia plymuthica)	4 / 7	ASN A 343 HIS A 349 PHE A 350 TRP A 312	None None None EDO A8008 (-4.0A)	1.49A	1tdnA-3gbdA: undetectable	1tdnA-3gbdA: 22.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2AOX_A_THAA400_1 (HISTAMINE N-METHYLTRANSFERASE)	3gbd	SUCROSE ISOMERASE SMUA FROM PROTAMINOBACTER RUBRUM (Serratia plymuthica)	4 / 8	PHE A 317 PHE A 524 TYR A 509 TYR A 496	None EDO A8008 ( 4.8A) None None	1.21A	2aoxA-3gbdA: undetectable	2aoxA-3gbdA: 19.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2DTT_C_H4BC1002_1 (HYPOTHETICAL PROTEIN PH0634)	3gbd	SUCROSE ISOMERASE SMUA FROM PROTAMINOBACTER RUBRUM (Serratia plymuthica)	4 / 6	TYR A 78 ASP A 75 PHE A 178 THR A 215	EDO A8003 ( 4.4A) EDO A8003 (-2.8A) EDO A8003 ( 3.9A) EDO A8001 ( 4.2A)	1.16A	2dttB-3gbdA: undetectable 2dttC-3gbdA: undetectable	2dttB-3gbdA: 11.89 2dttC-3gbdA: 11.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2FR3_A_REAA300_1 (CELLULAR RETINOIC ACID BINDING PROTEIN 2)	2cbr	PROTEIN (CRABP-I) (Bos taurus)	11 / 12	PHE A 15 LEU A 19 ALA A 32 ALA A 36 PRO A 39 THR A 54 THR A 56 VAL A 58 LEU A 120 ARG A 131 TYR A 133	None None A80 A 201 ( 4.1A) A80 A 201 ( 4.0A) A80 A 201 ( 4.9A) A80 A 201 (-3.5A) A80 A 201 (-3.3A) None None A80 A 201 (-3.8A) A80 A 201 (-4.7A)	0.47A	2fr3A-2cbrA: 26.9	2fr3A-2cbrA: 76.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2FR3_A_REAA300_1 (CELLULAR RETINOIC ACID BINDING PROTEIN 2)	2cbr	PROTEIN (CRABP-I) (Bos taurus)	5 / 12	PHE A 15 LEU A 19 ALA A 32 THR A 61 VAL A 58	None None A80 A 201 ( 4.1A) None None	0.99A	2fr3A-2cbrA: 26.9	2fr3A-2cbrA: 76.64
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2G78_A_REAA200_1 (CELLULAR RETINOIC ACID-BINDING PROTEIN 2)	2cbr	PROTEIN (CRABP-I) (Bos taurus)	9 / 12	PHE A 15 LEU A 19 ALA A 32 THR A 54 THR A 56 VAL A 58 VAL A 76 ARG A 111 LEU A 120	None None A80 A 201 ( 4.1A) A80 A 201 (-3.5A) A80 A 201 (-3.3A) None None None None	0.54A	2g78A-2cbrA: 26.9	2g78A-2cbrA: 75.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2G78_A_REAA200_1 (CELLULAR RETINOIC ACID-BINDING PROTEIN 2)	2cbr	PROTEIN (CRABP-I) (Bos taurus)	6 / 12	PHE A 15 LEU A 19 ALA A 32 THR A 61 VAL A 58 VAL A 76	None None A80 A 201 ( 4.1A) None None None	1.37A	2g78A-2cbrA: 26.9	2g78A-2cbrA: 75.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2KCE_A_D16A566_1 (THYMIDYLATE SYNTHASE)	3fzy	RTX TOXIN RTXA (Vibrio cholerae)	5 / 12	SER A3487 GLU A3485 ASP A3452 GLY A3453 LYS A3611	None None None None IHP A8000 (-2.9A)	1.20A	2kceA-3fzyA: undetectable	2kceA-3fzyA: 22.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Q8H_A_TF4A438_1 ([PYRUVATE DEHYDROGENASE [LIPOAMIDE]] KINASE ISOZYME 1)	2hiy	HYPOTHETICAL PROTEIN (Streptococcus pneumoniae)	4 / 6	LEU A 154 TYR A 150 ILE A 135 ILE A 165	GOL A8002 ( 4.5A) None None None	0.96A	2q8hA-2hiyA: undetectable	2q8hA-2hiyA: 21.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2QM9_A_TDZA201_1 (FATTY ACID-BINDING PROTEIN, ADIPOCYTE)	2cbr	PROTEIN (CRABP-I) (Bos taurus)	5 / 12	PHE A 15 ALA A 32 THR A 61 ARG A 131 TYR A 133	None A80 A 201 ( 4.1A) None A80 A 201 (-3.8A) A80 A 201 (-4.7A)	0.89A	2qm9A-2cbrA: 18.7	2qm9A-2cbrA: 32.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2QM9_A_TDZA201_1 (FATTY ACID-BINDING PROTEIN, ADIPOCYTE)	2cbr	PROTEIN (CRABP-I) (Bos taurus)	5 / 12	PHE A 15 ALA A 32 THR A 61 CYH A 129 TYR A 133	None A80 A 201 ( 4.1A) None None A80 A 201 (-4.7A)	1.38A	2qm9A-2cbrA: 18.7	2qm9A-2cbrA: 32.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2QM9_A_TDZA201_1 (FATTY ACID-BINDING PROTEIN, ADIPOCYTE)	2cbr	PROTEIN (CRABP-I) (Bos taurus)	5 / 12	PHE A 15 VAL A 24 ALA A 32 THR A 61 CYH A 129	None None A80 A 201 ( 4.1A) None None	1.22A	2qm9A-2cbrA: 18.7	2qm9A-2cbrA: 32.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QX4_B_ML1B233_1 (RIBOSYLDIHYDRONICOTI NAMIDE DEHYDROGENASE [QUINONE])	3gbd	SUCROSE ISOMERASE SMUA FROM PROTAMINOBACTER RUBRUM (Serratia plymuthica)	4 / 7	GLY A 271 THR A 241 PHE A 178 PHE A 159	None None EDO A8003 ( 3.9A) None	1.04A	2qx4A-3gbdA: undetectable 2qx4B-3gbdA: undetectable	2qx4A-3gbdA: 16.08 2qx4B-3gbdA: 16.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VCV_I_ASDI1224_1 (GLUTATHIONE S-TRANSFERASE A3)	2hiy	HYPOTHETICAL PROTEIN (Streptococcus pneumoniae)	5 / 9	LEU A 128 LEU A 103 ALA A 149 LEU A 154 PHE A 159	None None None GOL A8002 ( 4.5A) None	1.20A	2vcvI-2hiyA: undetectable	2vcvI-2hiyA: 23.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2XNR_A_ACTA1001_0 (NUCLEAR POLYADENYLATED RNA-BINDING PROTEIN 3)	1rzm	PHOSPHO-2-DEHYDRO-3- DEOXYHEPTONATE ALDOLASE (Thermotoga maritima)	3 / 3	SER A 271 ARG A 247 GLN A 312	None None CD A8001 ( 4.7A)	0.94A	2xnrA-1rzmA: 3.4	2xnrA-1rzmA: 14.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZQ9_A_CLSA11_1 (BETA-LACTAMASE TOHO-1)	3gbd	SUCROSE ISOMERASE SMUA FROM PROTAMINOBACTER RUBRUM (Serratia plymuthica)	4 / 4	GLU A 401 ARG A 429 ASN A 343 ASP A 342	EDO A8002 (-3.3A) EDO A8003 ( 3.2A) None EDO A8002 ( 3.5A)	1.40A	2zq9A-3gbdA: undetectable	2zq9A-3gbdA: 19.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZUL_A_SAMA376_0 (PROBABLE RIBOSOMAL RNA SMALL SUBUNIT METHYLTRANSFERASE)	3q3q	ALKALINE PHOSPHATASE (Sphingomonas sp. BSAR-1)	5 / 12	GLY A 492 ALA A 86 VAL A 476 PRO A 396 VAL A 366	GOL A8002 (-4.8A) GOL A8002 (-3.9A) None None None	1.10A	2zulA-3q3qA: undetectable	2zulA-3q3qA: 23.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZW9_B_SAMB801_1 (LEUCINE CARBOXYL METHYLTRANSFERASE 2)	3fzy	RTX TOXIN RTXA (Vibrio cholerae)	4 / 8	ILE A3584 LYS A3511 ARG A3457 SER A3632	UNX A 327 (-4.3A) CL A 1 ( 4.2A) IHP A8000 ( 4.0A) None	1.05A	2zw9B-3fzyA: undetectable	2zw9B-3fzyA: 15.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AIC_A_ACRA5044_1 (GLUCOSYLTRANSFERASE- SI)	3gbd	SUCROSE ISOMERASE SMUA FROM PROTAMINOBACTER RUBRUM (Serratia plymuthica)	6 / 12	ARG A 212 ASP A 214 GLU A 268 HIS A 341 ASP A 342 ASP A 75	None EDO A8003 ( 2.7A) EDO A8001 (-3.1A) None EDO A8002 ( 3.5A) EDO A8003 (-2.8A)	0.74A	3aicA-3gbdA: 4.6	3aicA-3gbdA: 21.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AIC_B_ACRB5044_1 (GLUCOSYLTRANSFERASE- SI)	3gbd	SUCROSE ISOMERASE SMUA FROM PROTAMINOBACTER RUBRUM (Serratia plymuthica)	6 / 12	ARG A 212 ASP A 214 GLU A 268 HIS A 341 ASP A 342 ASP A 75	None EDO A8003 ( 2.7A) EDO A8001 (-3.1A) None EDO A8002 ( 3.5A) EDO A8003 (-2.8A)	0.76A	3aicB-3gbdA: 3.3	3aicB-3gbdA: 21.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AIC_C_ACRC5044_1 (GLUCOSYLTRANSFERASE- SI)	3gbd	SUCROSE ISOMERASE SMUA FROM PROTAMINOBACTER RUBRUM (Serratia plymuthica)	7 / 12	ARG A 212 ASP A 214 GLU A 268 HIS A 341 ASP A 342 ASP A 75 TYR A 78	None EDO A8003 ( 2.7A) EDO A8001 (-3.1A) None EDO A8002 ( 3.5A) EDO A8003 (-2.8A) EDO A8003 ( 4.4A)	0.72A	3aicC-3gbdA: 7.5	3aicC-3gbdA: 21.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AIC_C_ACRC5044_1 (GLUCOSYLTRANSFERASE- SI)	3gbd	SUCROSE ISOMERASE SMUA FROM PROTAMINOBACTER RUBRUM (Serratia plymuthica)	6 / 12	ARG A 212 GLU A 268 HIS A 341 ASP A 342 TYR A 78 GLN A 182	None EDO A8001 (-3.1A) None EDO A8002 ( 3.5A) EDO A8003 ( 4.4A) None	1.03A	3aicC-3gbdA: 7.5	3aicC-3gbdA: 21.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AIC_D_ACRD5044_1 (GLUCOSYLTRANSFERASE- SI)	3gbd	SUCROSE ISOMERASE SMUA FROM PROTAMINOBACTER RUBRUM (Serratia plymuthica)	6 / 12	ARG A 212 ASP A 214 GLU A 268 HIS A 341 ASP A 342 ASP A 75	None EDO A8003 ( 2.7A) EDO A8001 (-3.1A) None EDO A8002 ( 3.5A) EDO A8003 (-2.8A)	0.82A	3aicD-3gbdA: 4.3	3aicD-3gbdA: 21.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AIC_E_ACRE5044_1 (GLUCOSYLTRANSFERASE- SI)	3gbd	SUCROSE ISOMERASE SMUA FROM PROTAMINOBACTER RUBRUM (Serratia plymuthica)	6 / 12	ARG A 212 ASP A 214 GLU A 268 HIS A 341 ASP A 342 ASP A 75	None EDO A8003 ( 2.7A) EDO A8001 (-3.1A) None EDO A8002 ( 3.5A) EDO A8003 (-2.8A)	0.80A	3aicE-3gbdA: 7.7	3aicE-3gbdA: 21.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AIC_F_ACRF5044_1 (GLUCOSYLTRANSFERASE- SI)	3gbd	SUCROSE ISOMERASE SMUA FROM PROTAMINOBACTER RUBRUM (Serratia plymuthica)	6 / 12	ARG A 212 ASP A 214 GLU A 268 HIS A 341 ASP A 342 ASP A 75	None EDO A8003 ( 2.7A) EDO A8001 (-3.1A) None EDO A8002 ( 3.5A) EDO A8003 (-2.8A)	0.80A	3aicF-3gbdA: 4.3	3aicF-3gbdA: 21.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AIC_G_ACRG5044_1 (GLUCOSYLTRANSFERASE- SI)	3gbd	SUCROSE ISOMERASE SMUA FROM PROTAMINOBACTER RUBRUM (Serratia plymuthica)	6 / 12	ARG A 212 ASP A 214 GLU A 268 HIS A 341 ASP A 342 ASP A 75	None EDO A8003 ( 2.7A) EDO A8001 (-3.1A) None EDO A8002 ( 3.5A) EDO A8003 (-2.8A)	0.77A	3aicG-3gbdA: 7.8	3aicG-3gbdA: 21.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AIC_H_ACRH5044_1 (GLUCOSYLTRANSFERASE- SI)	3gbd	SUCROSE ISOMERASE SMUA FROM PROTAMINOBACTER RUBRUM (Serratia plymuthica)	6 / 12	ARG A 212 ASP A 214 GLU A 268 HIS A 341 ASP A 342 ASP A 75	None EDO A8003 ( 2.7A) EDO A8001 (-3.1A) None EDO A8002 ( 3.5A) EDO A8003 (-2.8A)	0.78A	3aicH-3gbdA: 4.2	3aicH-3gbdA: 21.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3CWK_A_REAA300_1 (CELLULAR RETINOIC ACID-BINDING PROTEIN 2)	2cbr	PROTEIN (CRABP-I) (Bos taurus)	5 / 12	LEU A 28 PRO A 39 THR A 56 VAL A 58 ARG A 59	A80 A 201 ( 4.0A) A80 A 201 ( 4.9A) A80 A 201 (-3.3A) None A80 A 201 (-4.8A)	0.93A	3cwkA-2cbrA: 26.0	3cwkA-2cbrA: 72.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3CWK_A_REAA300_1 (CELLULAR RETINOIC ACID-BINDING PROTEIN 2)	2cbr	PROTEIN (CRABP-I) (Bos taurus)	8 / 12	PHE A 15 LEU A 19 LEU A 28 ALA A 32 ALA A 36 PRO A 39 THR A 56 VAL A 58	None None A80 A 201 ( 4.0A) A80 A 201 ( 4.1A) A80 A 201 ( 4.0A) A80 A 201 ( 4.9A) A80 A 201 (-3.3A) None	0.49A	3cwkA-2cbrA: 26.0	3cwkA-2cbrA: 72.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DMF_A_SAMA388_0 (PROBABLE RIBOSOMAL RNA SMALL SUBUNIT METHYLTRANSFERASE)	3q3q	ALKALINE PHOSPHATASE (Sphingomonas sp. BSAR-1)	5 / 12	GLY A 492 ALA A 86 VAL A 476 PRO A 396 VAL A 366	GOL A8002 (-4.8A) GOL A8002 (-3.9A) None None None	1.06A	3dmfA-3q3qA: undetectable	3dmfA-3q3qA: 23.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DMH_A_SAMA384_0 (PROBABLE RIBOSOMAL RNA SMALL SUBUNIT METHYLTRANSFERASE)	3q3q	ALKALINE PHOSPHATASE (Sphingomonas sp. BSAR-1)	5 / 12	GLY A 492 ALA A 86 VAL A 476 PRO A 396 VAL A 366	GOL A8002 (-4.8A) GOL A8002 (-3.9A) None None None	1.08A	3dmhA-3q3qA: undetectable	3dmhA-3q3qA: 23.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3P6G_A_IZPA133_1 (FATTY ACID-BINDING PROTEIN, ADIPOCYTE)	2cbr	PROTEIN (CRABP-I) (Bos taurus)	5 / 12	PHE A 15 PRO A 39 ARG A 111 ARG A 131 TYR A 133	None A80 A 201 ( 4.9A) None A80 A 201 (-3.8A) A80 A 201 (-4.7A)	0.66A	3p6gA-2cbrA: 18.8	3p6gA-2cbrA: 36.55
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3P6G_A_IZPA133_1 (FATTY ACID-BINDING PROTEIN, ADIPOCYTE)	2cbr	PROTEIN (CRABP-I) (Bos taurus)	5 / 12	PHE A 15 PRO A 39 CYH A 129 ARG A 131 TYR A 133	None A80 A 201 ( 4.9A) None A80 A 201 (-3.8A) A80 A 201 (-4.7A)	1.40A	3p6gA-2cbrA: 18.8	3p6gA-2cbrA: 36.55
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3QXT_B_MTXB2000_1 (ANTI-METHOTREXATE CDR1-3 GRAFT VHH)	1sjx	IMMUNOGLOBULIN VH DOMAIN (Lama glama)	6 / 12	VAL A 802 LEU A 804 MET A 834 VAL A 878 ALA A 897 TYR A 908	None None MPD A8001 ( 3.5A) None None None	0.87A	3qxtB-1sjxA: 21.0	3qxtB-1sjxA: 69.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TMZ_A_06XA503_1 (CYTOCHROME P450 2B4)	1rzm	PHOSPHO-2-DEHYDRO-3- DEOXYHEPTONATE ALDOLASE (Thermotoga maritima)	5 / 11	ILE A 233 ILE A 224 GLU A 164 PRO A 203 VAL A 162	None None PEP A8002 ( 4.8A) None None	1.11A	3tmzA-1rzmA: undetectable	3tmzA-1rzmA: 21.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3V3N_A_MIYA2001_1 (TETX2 PROTEIN)	1sjx	IMMUNOGLOBULIN VH DOMAIN (Lama glama)	5 / 11	GLN A 911 MET A 834 GLY A 910 GLY A 826 ASN A 876	None MPD A8001 ( 3.5A) None None None	1.39A	3v3nA-1sjxA: undetectable	3v3nA-1sjxA: 17.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3V3N_D_MIYD2001_1 (TETX2 PROTEIN)	1sjx	IMMUNOGLOBULIN VH DOMAIN (Lama glama)	5 / 11	GLN A 911 MET A 834 GLY A 910 GLY A 826 ASN A 876	None MPD A8001 ( 3.5A) None None None	1.39A	3v3nD-1sjxA: undetectable	3v3nD-1sjxA: 17.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4A99_D_MIYD391_1 (TETX2 PROTEIN)	1sjx	IMMUNOGLOBULIN VH DOMAIN (Lama glama)	5 / 11	GLN A 911 MET A 834 GLY A 910 GLY A 826 ASN A 876	None MPD A8001 ( 3.5A) None None None	1.42A	4a99D-1sjxA: undetectable	4a99D-1sjxA: 16.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4AN2_A_EUIA1382_1 (DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1)	3dtc	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	6 / 12	MET A 220 ASP A 268 LYS A 270 ASN A 273 GLY A 296 GLY A 311	VIN A6331 (-3.7A) SO4 A8001 ( 4.8A) SO4 A8001 (-3.0A) VIN A6331 ( 4.8A) None None	0.97A	4an2A-3dtcA: 25.9	4an2A-3dtcA: 28.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4CKJ_A_ADNA2014_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET)	3dtc	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	6 / 10	GLY A 151 GLY A 153 VAL A 158 ALA A 169 ALA A 223 LEU A 275	VIN A6331 (-3.5A) SO4 A8001 ( 4.3A) VIN A6331 (-4.7A) VIN A6331 (-3.4A) VIN A6331 (-3.8A) VIN A6331 (-4.5A)	0.51A	4ckjA-3dtcA: 26.8	4ckjA-3dtcA: 33.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DTZ_A_LDPA501_1 (CYTOCHROME P450 BM3 VARIANT 8C8)	3gbd	SUCROSE ISOMERASE SMUA FROM PROTAMINOBACTER RUBRUM (Serratia plymuthica)	4 / 6	PHE A 524 ALA A 364 LEU A 368 THR A 367	EDO A8008 ( 4.8A) None None None	0.98A	4dtzA-3gbdA: undetectable	4dtzA-3gbdA: 21.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4I41_A_MIXA500_1 (SERINE/THREONINE-PRO TEIN KINASE PIM-1)	3dtc	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	8 / 12	PHE A 155 VAL A 158 ALA A 169 ILE A 204 ASP A 268 ASN A 273 LEU A 275 ASP A 294	VIN A6331 ( 2.9A) VIN A6331 (-4.7A) VIN A6331 (-3.4A) VIN A6331 ( 4.9A) SO4 A8001 ( 4.8A) VIN A6331 ( 4.8A) VIN A6331 (-4.5A) VIN A6331 (-4.0A)	0.86A	4i41A-3dtcA: 22.0	4i41A-3dtcA: 28.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4I41_A_MIXA500_1 (SERINE/THREONINE-PRO TEIN KINASE PIM-1)	3dtc	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	8 / 12	PHE A 155 VAL A 158 ALA A 169 ILE A 204 ASP A 268 LYS A 270 ASN A 273 LEU A 275	VIN A6331 ( 2.9A) VIN A6331 (-4.7A) VIN A6331 (-3.4A) VIN A6331 ( 4.9A) SO4 A8001 ( 4.8A) SO4 A8001 (-3.0A) VIN A6331 ( 4.8A) VIN A6331 (-4.5A)	0.87A	4i41A-3dtcA: 22.0	4i41A-3dtcA: 28.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4L9I_B_8PRB601_1 (RHODOPSIN KINASE)	3dtc	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	5 / 8	GLY A 153 VAL A 158 ALA A 169 LYS A 171 MET A 220	SO4 A8001 ( 4.3A) VIN A6331 (-4.7A) VIN A6331 (-3.4A) None VIN A6331 (-3.7A)	1.05A	4l9iB-3dtcA: 19.7	4l9iB-3dtcA: 22.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4L9I_B_8PRB601_1 (RHODOPSIN KINASE)	3dtc	MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9 (Homo sapiens)	5 / 8	GLY A 153 VAL A 158 ALA A 169 MET A 220 LEU A 275	SO4 A8001 ( 4.3A) VIN A6331 (-4.7A) VIN A6331 (-3.4A) VIN A6331 (-3.7A) VIN A6331 (-4.5A)	0.63A	4l9iB-3dtcA: 19.7	4l9iB-3dtcA: 22.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4MJ8_A_SPMA202_1 (SPERMIDINE N1-ACETYLTRANSFERASE)	1d8c	MALATE SYNTHASE G (Escherichia coli)	4 / 8	ILE A 260 GLU A 239 GLN A 241 ILE A 242	SO4 A8000 (-3.9A) SO4 A8000 ( 4.7A) SO4 A8000 (-3.6A) None	0.79A	4mj8A-1d8cA: undetectable	4mj8A-1d8cA: 12.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O8J_A_ADNA401_1 (RNA 3'-TERMINAL PHOSPHATE CYCLASE)	3fzy	RTX TOXIN RTXA (Vibrio cholerae)	5 / 12	GLN A3461 ARG A3513 GLN A3515 ASP A3606 HIS A3483	None IHP A8000 (-2.6A) IHP A8000 ( 4.4A) None IHP A8000 (-3.8A)	1.19A	4o8jA-3fzyA: 0.0	4o8jA-3fzyA: 20.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O8J_B_ADNB401_1 (RNA 3'-TERMINAL PHOSPHATE CYCLASE)	3fzy	RTX TOXIN RTXA (Vibrio cholerae)	5 / 12	GLN A3461 ARG A3513 GLN A3515 ASP A3606 HIS A3483	None IHP A8000 (-2.6A) IHP A8000 ( 4.4A) None IHP A8000 (-3.8A)	1.14A	4o8jB-3fzyA: 0.1	4o8jB-3fzyA: 20.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PEV_A_ADNA501_1 (MEMBRANE LIPOPROTEIN FAMILY PROTEIN)	3gbd	SUCROSE ISOMERASE SMUA FROM PROTAMINOBACTER RUBRUM (Serratia plymuthica)	5 / 12	VAL A 402 SER A 157 PHE A 159 ASP A 75 GLY A 160	None None None EDO A8003 (-2.8A) EDO A8004 (-3.7A)	1.49A	4pevA-3gbdA: 1.3	4pevA-3gbdA: 20.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QOI_A_ML1A303_1 (RIBOSYLDIHYDRONICOTI NAMIDE DEHYDROGENASE [QUINONE])	3gbd	SUCROSE ISOMERASE SMUA FROM PROTAMINOBACTER RUBRUM (Serratia plymuthica)	4 / 8	TYR A 240 PHE A 236 GLY A 160 ILE A 400	None EDO A8004 (-4.8A) EDO A8004 (-3.7A) None	0.90A	4qoiA-3gbdA: undetectable 4qoiB-3gbdA: undetectable	4qoiA-3gbdA: 16.08 4qoiB-3gbdA: 16.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4QYN_A_RTLA201_0 (RETINOL-BINDING PROTEIN 2)	2cbr	PROTEIN (CRABP-I) (Bos taurus)	5 / 12	PHE A 15 ALA A 32 THR A 54 TRP A 109 LEU A 120	None A80 A 201 ( 4.1A) A80 A 201 (-3.5A) None None	0.75A	4qynA-2cbrA: 20.1	4qynA-2cbrA: 35.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4QZU_B_RTLB201_0 (RETINOL-BINDING PROTEIN 2)	2cbr	PROTEIN (CRABP-I) (Bos taurus)	5 / 12	PHE A 15 ALA A 32 THR A 54 TRP A 109 LEU A 120	None A80 A 201 ( 4.1A) A80 A 201 (-3.5A) None None	0.65A	4qzuB-2cbrA: 20.3	4qzuB-2cbrA: 35.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B3S_P_CHDP306_0 (CYTOCHROME C OXIDASE SUBUNIT 3)	3l8m	PROBABLE THIAMINE PYROPHOSPHOKINASE (Staphylococcus saprophyticus)	4 / 7	LYS A 126 LEU A 127 PHE A 106 LEU A 110	NA A8001 (-4.8A) None None None	0.82A	5b3sP-3l8mA: undetectable	5b3sP-3l8mA: 19.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5CSY_B_ACRB601_1 (4-ALPHA-GLUCANOTRANS FERASE DPE1, CHLOROPLASTIC/AMYLOP LASTIC)	3gbd	SUCROSE ISOMERASE SMUA FROM PROTAMINOBACTER RUBRUM (Serratia plymuthica)	5 / 12	ARG A 212 ASP A 214 GLU A 268 HIS A 341 ASP A 342	None EDO A8003 ( 2.7A) EDO A8001 (-3.1A) None EDO A8002 ( 3.5A)	0.47A	5csyB-3gbdA: 17.5	5csyB-3gbdA: 19.87
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5H8T_A_RTLA201_0 (RETINOL-BINDING PROTEIN 1)	2cbr	PROTEIN (CRABP-I) (Bos taurus)	5 / 12	PHE A 15 LEU A 19 ALA A 32 ILE A 52 LEU A 120	None None A80 A 201 ( 4.1A) None None	0.55A	5h8tA-2cbrA: 19.8	5h8tA-2cbrA: 41.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VCY_A_DB8A401_2 (MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2-INHIBITORY KINASE)	3gbd	SUCROSE ISOMERASE SMUA FROM PROTAMINOBACTER RUBRUM (Serratia plymuthica)	4 / 4	VAL A 468 LEU A 58 ASN A 463 ASP A 439	EDO A8005 (-4.6A) None None None	1.35A	5vcyA-3gbdA: 2.4	5vcyA-3gbdA: 19.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6AG0_A_ACRA610_0 (ALPHA-AMYLASE)	3gbd	SUCROSE ISOMERASE SMUA FROM PROTAMINOBACTER RUBRUM (Serratia plymuthica)	5 / 12	TYR A 78 HIS A 118 ASP A 214 HIS A 341 ASP A 342	EDO A8003 ( 4.4A) EDO A8003 (-4.8A) EDO A8003 ( 2.7A) None EDO A8002 ( 3.5A)	0.42A	6ag0A-3gbdA: 19.5	6ag0A-3gbdA: 11.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B58_A_ACTA607_0 (FUMARATE REDUCTASE FLAVOPROTEIN SUBUNIT)	1rzm	PHOSPHO-2-DEHYDRO-3- DEOXYHEPTONATE ALDOLASE (Thermotoga maritima)	4 / 4	GLY A 274 ARG A 237 ASN A 248 LEU A 250	None PEP A8002 (-3.9A) None None	1.18A	6b58A-1rzmA: undetectable	6b58A-1rzmA: 23.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BPL_B_PA1B605_1 (LIPID A EXPORT ATP-BINDING/PERMEASE PROTEIN MSBA)	1rzm	PHOSPHO-2-DEHYDRO-3- DEOXYHEPTONATE ALDOLASE (Thermotoga maritima)	3 / 3	ARG A 247 ARG A 126 ARG A 133	None PEP A8002 (-3.2A) E4P A8003 (-4.1A)	1.08A	6bplA-1rzmA: undetectable 6bplB-1rzmA: 0.8	6bplA-1rzmA: 16.85 6bplB-1rzmA: 16.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BPL_B_PA1B605_1 (LIPID A EXPORT ATP-BINDING/PERMEASE PROTEIN MSBA)	1rzm	PHOSPHO-2-DEHYDRO-3- DEOXYHEPTONATE ALDOLASE (Thermotoga maritima)	3 / 3	ARG A 247 ARG A 126 ARG A 237	None PEP A8002 (-3.2A) PEP A8002 (-3.9A)	1.09A	6bplA-1rzmA: undetectable 6bplB-1rzmA: 0.8	6bplA-1rzmA: 16.85 6bplB-1rzmA: 16.85

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1CBR_A_REAA200_1","CELLULAR RETINOIC ACID BINDING PROTEIN TYPE I","2cbr","PROTEIN (CRABP-I)","Bos taurus",6,"LEU A  28;ALA A  32;ALA A  35;THR A  54;THR A  56;ARG A  59","A80 A 201 ( 4.0A);A80 A 201 ( 4.1A);A80 A 201 ( 4.1A);A80 A 201 (-3.5A);A80 A 201 (-3.3A);A80 A 201 (-4.8A)","1.37A","1cbrA-2cbrA:27.2",null],["1CBR_A_REAA200_1","CELLULAR RETINOIC ACID BINDING PROTEIN TYPE I","2cbr","PROTEIN (CRABP-I)","Bos taurus",12,"PHE A  15;LEU A  28;ALA A  32;ALA A  36;PRO A  39;THR A  54;THR A  56;VAL A  58;ARG A  59;LEU A 120;ARG A 131;TYR A 133","None;A80 A 201 ( 4.0A);A80 A 201 ( 4.1A);A80 A 201 ( 4.0A);A80 A 201 ( 4.9A);A80 A 201 (-3.5A);A80 A 201 (-3.3A);None;A80 A 201 (-4.8A);None;A80 A 201 (-3.8A);A80 A 201 (-4.7A)","0.43A","1cbrA-2cbrA:27.2","1cbrA-2cbrA:100.00"],["1CBR_B_REAB200_1","CELLULAR RETINOIC ACID BINDING PROTEIN TYPE I","2cbr","PROTEIN (CRABP-I)","Bos taurus",6,"LEU A  28;ALA A  32;ALA A  35;THR A  54;THR A  56;ARG A  59","A80 A 201 ( 4.0A);A80 A 201 ( 4.1A);A80 A 201 ( 4.1A);A80 A 201 (-3.5A);A80 A 201 (-3.3A);A80 A 201 (-4.8A)","1.37A","1cbrB-2cbrA:27.3","1cbrA-2cbrA:100.00"],["1CBR_B_REAB200_1","CELLULAR RETINOIC ACID BINDING PROTEIN TYPE I","2cbr","PROTEIN (CRABP-I)","Bos taurus",12,"PHE A  15;LEU A  28;ALA A  32;ALA A  36;PRO A  39;THR A  54;THR A  56;VAL A  58;ARG A  59;LEU A 120;ARG A 131;TYR A 133","None;A80 A 201 ( 4.0A);A80 A 201 ( 4.1A);A80 A 201 ( 4.0A);A80 A 201 ( 4.9A);A80 A 201 (-3.5A);A80 A 201 (-3.3A);None;A80 A 201 (-4.8A);None;A80 A 201 (-3.8A);A80 A 201 (-4.7A)","0.43A","1cbrB-2cbrA:27.3","1cbrB-2cbrA:100.00"],["1CBS_A_REAA200_1","CELLULAR RETINOIC ACID BINDING PROTEIN TYPE II","2cbr","PROTEIN (CRABP-I)","Bos taurus",11,"PHE A  15;LEU A  19;ALA A  32;ALA A  36;PRO A  39;THR A  54;THR A  56;VAL A  58;LEU A 120;ARG A 131;TYR A 133","None;None;A80 A 201 ( 4.1A);A80 A 201 ( 4.0A);A80 A 201 ( 4.9A);A80 A 201 (-3.5A);A80 A 201 (-3.3A);None;None;A80 A 201 (-3.8A);A80 A 201 (-4.7A)","0.45A","1cbsA-2cbrA:26.6","1cbrB-2cbrA:100.00"],["1CBS_A_REAA200_1","CELLULAR RETINOIC ACID BINDING PROTEIN TYPE II","2cbr","PROTEIN (CRABP-I)","Bos taurus",5,"PHE A  15;LEU A  19;ALA A  32;THR A  61;VAL A  58","None;None;A80 A 201 ( 4.1A);None;None","0.91A","1cbsA-2cbrA:26.6","1cbsA-2cbrA:76.64"],["1CRB_A_RTLA200_0","CELLULAR RETINOL BINDING PROTEIN","2cbr","PROTEIN (CRABP-I)","Bos taurus",5,"LEU A  19;ALA A  32;ILE A  63;THR A  61;TRP A 109","None;A80 A 201 ( 4.1A);None;None;None","0.89A","1crbA-2cbrA:15.7","1cbsA-2cbrA:76.64"],["1CRB_A_RTLA200_0","CELLULAR RETINOL BINDING PROTEIN","2cbr","PROTEIN (CRABP-I)","Bos taurus",5,"PHE A  15;ALA A  32;ILE A  52;THR A  54;TRP A 109","None;A80 A 201 ( 4.1A);None;A80 A 201 (-3.5A);None","0.82A","1crbA-2cbrA:15.7","1crbA-2cbrA:42.14"],["1CRB_A_RTLA200_0","CELLULAR RETINOL BINDING PROTEIN","2cbr","PROTEIN (CRABP-I)","Bos taurus",5,"PHE A  15;LEU A  19;ALA A  32;ILE A  52;TRP A 109","None;None;A80 A 201 ( 4.1A);None;None","0.94A","1crbA-2cbrA:15.7","1crbA-2cbrA:42.14"],["1CRB_A_RTLA200_0","CELLULAR RETINOL BINDING PROTEIN","2cbr","PROTEIN (CRABP-I)","Bos taurus",5,"PHE A  15;LEU A  19;ALA A  32;ILE A  63;TRP A 109","None;None;A80 A 201 ( 4.1A);None;None","0.90A","1crbA-2cbrA:15.7","1crbA-2cbrA:42.14"],["1DED_B_QPSB1501_1","CYCLODEXTRIN GLUCANOTRANSFERASE","3gbd","SUCROSE ISOMERASE SMUA FROM PROTAMINOBACTER RUBRUM","Serratia plymuthica",7,"TYR A  78;ARG A 212;ASP A 214;GLU A 268;HIS A 341;ASP A 342;ARG A 433","EDO A8003 ( 4.4A);None;EDO A8003 ( 2.7A);EDO A8001 (-3.1A);None;EDO A8002 ( 3.5A);None","0.80A","1dedB-3gbdA:27.0","1crbA-2cbrA:42.14"],["1MX8_A_RTLA135_0","CELLULAR RETINOL-BINDING PROTEIN I, HOLO","2cbr","PROTEIN (CRABP-I)","Bos taurus",5,"PHE A  15;LEU A  19;ALA A  32;THR A  61;PHE A  71","None;None;A80 A 201 ( 4.1A);None;None","0.87A","1mx8A-2cbrA:16.7","1dedB-3gbdA:26.24"],["1MXD_A_ACRA735_1","ALPHA AMYLASE","3gbd","SUCROSE ISOMERASE SMUA FROM PROTAMINOBACTER RUBRUM","Serratia plymuthica",8,"TYR A  78;HIS A 118;PHE A 178;ARG A 212;ASP A 214;GLU A 268;HIS A 341;ASP A 342","EDO A8003 ( 4.4A);EDO A8003 (-4.8A);EDO A8003 ( 3.9A);None;EDO A8003 ( 2.7A);EDO A8001 (-3.1A);None;EDO A8002 ( 3.5A)","0.98A","1mxdA-3gbdA:22.3","1mx8A-2cbrA:42.14"],["1QKN_A_RALA600_2","ESTROGEN RECEPTOR BETA","3q3q","ALKALINE PHOSPHATASE","Sphingomonas sp. BSAR-1",3,"ASP A 399;LEU A 469;HIS A 346","None;GOL A8002 ( 4.8A); ZN A1559 ( 3.2A)","0.59A","1qknA-3q3qA:undetectable","1mxdA-3gbdA:23.26"],["1TDN_A_LEUA487_0","L-AMINO ACID OXIDASE","3gbd","SUCROSE ISOMERASE SMUA FROM PROTAMINOBACTER RUBRUM","Serratia plymuthica",4,"ASN A 343;HIS A 349;PHE A 350;TRP A 312","None;None;None;EDO A8008 (-4.0A)","1.49A","1tdnA-3gbdA:undetectable","1qknA-3q3qA:17.91"],["2AOX_A_THAA400_1","HISTAMINE N-METHYLTRANSFERASE","3gbd","SUCROSE ISOMERASE SMUA FROM PROTAMINOBACTER RUBRUM","Serratia plymuthica",4,"PHE A 317;PHE A 524;TYR A 509;TYR A 496","None;EDO A8008 ( 4.8A);None;None","1.21A","2aoxA-3gbdA:undetectable","1tdnA-3gbdA:22.35"],["2DTT_C_H4BC1002_1","HYPOTHETICAL PROTEIN PH0634;HYPOTHETICAL PROTEIN PH0634","3gbd","SUCROSE ISOMERASE SMUA FROM PROTAMINOBACTER RUBRUM","Serratia plymuthica",4,"TYR A  78;ASP A  75;PHE A 178;THR A 215","EDO A8003 ( 4.4A);EDO A8003 (-2.8A);EDO A8003 ( 3.9A);EDO A8001 ( 4.2A)","1.16A","2dttB-3gbdA:undetectable;2dttC-3gbdA:undetectable","2aoxA-3gbdA:19.13"],["2FR3_A_REAA300_1","CELLULAR RETINOIC ACID BINDING PROTEIN 2","2cbr","PROTEIN (CRABP-I)","Bos taurus",11,"PHE A  15;LEU A  19;ALA A  32;ALA A  36;PRO A  39;THR A  54;THR A  56;VAL A  58;LEU A 120;ARG A 131;TYR A 133","None;None;A80 A 201 ( 4.1A);A80 A 201 ( 4.0A);A80 A 201 ( 4.9A);A80 A 201 (-3.5A);A80 A 201 (-3.3A);None;None;A80 A 201 (-3.8A);A80 A 201 (-4.7A)","0.47A","2fr3A-2cbrA:26.9","2dttB-3gbdA:11.89;2dttC-3gbdA:11.89"],["2FR3_A_REAA300_1","CELLULAR RETINOIC ACID BINDING PROTEIN 2","2cbr","PROTEIN (CRABP-I)","Bos taurus",5,"PHE A  15;LEU A  19;ALA A  32;THR A  61;VAL A  58","None;None;A80 A 201 ( 4.1A);None;None","0.99A","2fr3A-2cbrA:26.9","2fr3A-2cbrA:76.64"],["2G78_A_REAA200_1","CELLULAR RETINOIC ACID-BINDING PROTEIN 2","2cbr","PROTEIN (CRABP-I)","Bos taurus",9,"PHE A  15;LEU A  19;ALA A  32;THR A  54;THR A  56;VAL A  58;VAL A  76;ARG A 111;LEU A 120","None;None;A80 A 201 ( 4.1A);A80 A 201 (-3.5A);A80 A 201 (-3.3A);None;None;None;None","0.54A","2g78A-2cbrA:26.9","2fr3A-2cbrA:76.64"],["2G78_A_REAA200_1","CELLULAR RETINOIC ACID-BINDING PROTEIN 2","2cbr","PROTEIN (CRABP-I)","Bos taurus",6,"PHE A  15;LEU A  19;ALA A  32;THR A  61;VAL A  58;VAL A  76","None;None;A80 A 201 ( 4.1A);None;None;None","1.37A","2g78A-2cbrA:26.9","2g78A-2cbrA:75.18"],["2KCE_A_D16A566_1","THYMIDYLATE SYNTHASE","3fzy","RTX TOXIN RTXA","Vibrio cholerae",5,"SER A3487;GLU A3485;ASP A3452;GLY A3453;LYS A3611","None;None;None;None;IHP A8000 (-2.9A)","1.20A","2kceA-3fzyA:undetectable","2g78A-2cbrA:75.18"],["2Q8H_A_TF4A438_1","[PYRUVATE DEHYDROGENASE [LIPOAMIDE]] KINASE ISOZYME 1","2hiy","HYPOTHETICAL PROTEIN","Streptococcus pneumoniae",4,"LEU A 154;TYR A 150;ILE A 135;ILE A 165","GOL A8002 ( 4.5A);None;None;None","0.96A","2q8hA-2hiyA:undetectable","2kceA-3fzyA:22.11"],["2QM9_A_TDZA201_1","FATTY ACID-BINDING PROTEIN, ADIPOCYTE","2cbr","PROTEIN (CRABP-I)","Bos taurus",5,"PHE A  15;ALA A  32;THR A  61;ARG A 131;TYR A 133","None;A80 A 201 ( 4.1A);None;A80 A 201 (-3.8A);A80 A 201 (-4.7A)","0.89A","2qm9A-2cbrA:18.7","2q8hA-2hiyA:21.45"],["2QM9_A_TDZA201_1","FATTY ACID-BINDING PROTEIN, ADIPOCYTE","2cbr","PROTEIN (CRABP-I)","Bos taurus",5,"PHE A  15;ALA A  32;THR A  61;CYH A 129;TYR A 133","None;A80 A 201 ( 4.1A);None;None;A80 A 201 (-4.7A)","1.38A","2qm9A-2cbrA:18.7","2qm9A-2cbrA:32.92"],["2QM9_A_TDZA201_1","FATTY ACID-BINDING PROTEIN, ADIPOCYTE","2cbr","PROTEIN (CRABP-I)","Bos taurus",5,"PHE A  15;VAL A  24;ALA A  32;THR A  61;CYH A 129","None;None;A80 A 201 ( 4.1A);None;None","1.22A","2qm9A-2cbrA:18.7","2qm9A-2cbrA:32.92"],["2QX4_B_ML1B233_1","RIBOSYLDIHYDRONICOTINAMIDE DEHYDROGENASE [QUINONE];RIBOSYLDIHYDRONICOTINAMIDE DEHYDROGENASE [QUINONE]","3gbd","SUCROSE ISOMERASE SMUA FROM PROTAMINOBACTER RUBRUM","Serratia plymuthica",4,"GLY A 271;THR A 241;PHE A 178;PHE A 159","None;None;EDO A8003 ( 3.9A);None","1.04A","2qx4A-3gbdA:undetectable;2qx4B-3gbdA:undetectable","2qm9A-2cbrA:32.92"],["2VCV_I_ASDI1224_1","GLUTATHIONE S-TRANSFERASE A3","2hiy","HYPOTHETICAL PROTEIN","Streptococcus pneumoniae",5,"LEU A 128;LEU A 103;ALA A 149;LEU A 154;PHE A 159","None;None;None;GOL A8002 ( 4.5A);None","1.20A","2vcvI-2hiyA:undetectable","2qx4A-3gbdA:16.08;2qx4B-3gbdA:16.08"],["2XNR_A_ACTA1001_0","NUCLEAR POLYADENYLATED RNA-BINDING PROTEIN 3","1rzm","PHOSPHO-2-DEHYDRO-3-DEOXYHEPTONATE ALDOLASE","Thermotoga maritima",3,"SER A 271;ARG A 247;GLN A 312","None;None; CD A8001 ( 4.7A)","0.94A","2xnrA-1rzmA:3.4","2vcvI-2hiyA:23.04"],["2ZQ9_A_CLSA11_1","BETA-LACTAMASE TOHO-1","3gbd","SUCROSE ISOMERASE SMUA FROM PROTAMINOBACTER RUBRUM","Serratia plymuthica",4,"GLU A 401;ARG A 429;ASN A 343;ASP A 342","EDO A8002 (-3.3A);EDO A8003 ( 3.2A);None;EDO A8002 ( 3.5A)","1.40A","2zq9A-3gbdA:undetectable","2xnrA-1rzmA:14.91"],["2ZUL_A_SAMA376_0","PROBABLE RIBOSOMAL RNA SMALL SUBUNIT METHYLTRANSFERASE","3q3q","ALKALINE PHOSPHATASE","Sphingomonas sp. BSAR-1",5,"GLY A 492;ALA A  86;VAL A 476;PRO A 396;VAL A 366","GOL A8002 (-4.8A);GOL A8002 (-3.9A);None;None;None","1.10A","2zulA-3q3qA:undetectable","2zq9A-3gbdA:19.38"],["2ZW9_B_SAMB801_1","LEUCINE CARBOXYL METHYLTRANSFERASE 2","3fzy","RTX TOXIN RTXA","Vibrio cholerae",4,"ILE A3584;LYS A3511;ARG A3457;SER A3632","UNX A 327 (-4.3A); CL A   1 ( 4.2A);IHP A8000 ( 4.0A);None","1.05A","2zw9B-3fzyA:undetectable","2zulA-3q3qA:23.17"],["3AIC_A_ACRA5044_1","GLUCOSYLTRANSFERASE-SI","3gbd","SUCROSE ISOMERASE SMUA FROM PROTAMINOBACTER RUBRUM","Serratia plymuthica",6,"ARG A 212;ASP A 214;GLU A 268;HIS A 341;ASP A 342;ASP A  75","None;EDO A8003 ( 2.7A);EDO A8001 (-3.1A);None;EDO A8002 ( 3.5A);EDO A8003 (-2.8A)","0.74A","3aicA-3gbdA:4.6","2zw9B-3fzyA:15.14"],["3AIC_B_ACRB5044_1","GLUCOSYLTRANSFERASE-SI","3gbd","SUCROSE ISOMERASE SMUA FROM PROTAMINOBACTER RUBRUM","Serratia plymuthica",6,"ARG A 212;ASP A 214;GLU A 268;HIS A 341;ASP A 342;ASP A  75","None;EDO A8003 ( 2.7A);EDO A8001 (-3.1A);None;EDO A8002 ( 3.5A);EDO A8003 (-2.8A)","0.76A","3aicB-3gbdA:3.3","3aicA-3gbdA:21.00"],["3AIC_C_ACRC5044_1","GLUCOSYLTRANSFERASE-SI","3gbd","SUCROSE ISOMERASE SMUA FROM PROTAMINOBACTER RUBRUM","Serratia plymuthica",7,"ARG A 212;ASP A 214;GLU A 268;HIS A 341;ASP A 342;ASP A  75;TYR A  78","None;EDO A8003 ( 2.7A);EDO A8001 (-3.1A);None;EDO A8002 ( 3.5A);EDO A8003 (-2.8A);EDO A8003 ( 4.4A)","0.72A","3aicC-3gbdA:7.5","3aicB-3gbdA:21.00"],["3AIC_C_ACRC5044_1","GLUCOSYLTRANSFERASE-SI","3gbd","SUCROSE ISOMERASE SMUA FROM PROTAMINOBACTER RUBRUM","Serratia plymuthica",6,"ARG A 212;GLU A 268;HIS A 341;ASP A 342;TYR A  78;GLN A 182","None;EDO A8001 (-3.1A);None;EDO A8002 ( 3.5A);EDO A8003 ( 4.4A);None","1.03A","3aicC-3gbdA:7.5","3aicC-3gbdA:21.00"],["3AIC_D_ACRD5044_1","GLUCOSYLTRANSFERASE-SI","3gbd","SUCROSE ISOMERASE SMUA FROM PROTAMINOBACTER RUBRUM","Serratia plymuthica",6,"ARG A 212;ASP A 214;GLU A 268;HIS A 341;ASP A 342;ASP A  75","None;EDO A8003 ( 2.7A);EDO A8001 (-3.1A);None;EDO A8002 ( 3.5A);EDO A8003 (-2.8A)","0.82A","3aicD-3gbdA:4.3","3aicC-3gbdA:21.00"],["3AIC_E_ACRE5044_1","GLUCOSYLTRANSFERASE-SI","3gbd","SUCROSE ISOMERASE SMUA FROM PROTAMINOBACTER RUBRUM","Serratia plymuthica",6,"ARG A 212;ASP A 214;GLU A 268;HIS A 341;ASP A 342;ASP A  75","None;EDO A8003 ( 2.7A);EDO A8001 (-3.1A);None;EDO A8002 ( 3.5A);EDO A8003 (-2.8A)","0.80A","3aicE-3gbdA:7.7","3aicD-3gbdA:21.00"],["3AIC_F_ACRF5044_1","GLUCOSYLTRANSFERASE-SI","3gbd","SUCROSE ISOMERASE SMUA FROM PROTAMINOBACTER RUBRUM","Serratia plymuthica",6,"ARG A 212;ASP A 214;GLU A 268;HIS A 341;ASP A 342;ASP A  75","None;EDO A8003 ( 2.7A);EDO A8001 (-3.1A);None;EDO A8002 ( 3.5A);EDO A8003 (-2.8A)","0.80A","3aicF-3gbdA:4.3","3aicE-3gbdA:21.00"],["3AIC_G_ACRG5044_1","GLUCOSYLTRANSFERASE-SI","3gbd","SUCROSE ISOMERASE SMUA FROM PROTAMINOBACTER RUBRUM","Serratia plymuthica",6,"ARG A 212;ASP A 214;GLU A 268;HIS A 341;ASP A 342;ASP A  75","None;EDO A8003 ( 2.7A);EDO A8001 (-3.1A);None;EDO A8002 ( 3.5A);EDO A8003 (-2.8A)","0.77A","3aicG-3gbdA:7.8","3aicF-3gbdA:21.00"],["3AIC_H_ACRH5044_1","GLUCOSYLTRANSFERASE-SI","3gbd","SUCROSE ISOMERASE SMUA FROM PROTAMINOBACTER RUBRUM","Serratia plymuthica",6,"ARG A 212;ASP A 214;GLU A 268;HIS A 341;ASP A 342;ASP A  75","None;EDO A8003 ( 2.7A);EDO A8001 (-3.1A);None;EDO A8002 ( 3.5A);EDO A8003 (-2.8A)","0.78A","3aicH-3gbdA:4.2","3aicG-3gbdA:21.00"],["3CWK_A_REAA300_1","CELLULAR RETINOIC ACID-BINDING PROTEIN 2","2cbr","PROTEIN (CRABP-I)","Bos taurus",5,"LEU A  28;PRO A  39;THR A  56;VAL A  58;ARG A  59","A80 A 201 ( 4.0A);A80 A 201 ( 4.9A);A80 A 201 (-3.3A);None;A80 A 201 (-4.8A)","0.93A","3cwkA-2cbrA:26.0","3aicH-3gbdA:21.00"],["3CWK_A_REAA300_1","CELLULAR RETINOIC ACID-BINDING PROTEIN 2","2cbr","PROTEIN (CRABP-I)","Bos taurus",8,"PHE A  15;LEU A  19;LEU A  28;ALA A  32;ALA A  36;PRO A  39;THR A  56;VAL A  58","None;None;A80 A 201 ( 4.0A);A80 A 201 ( 4.1A);A80 A 201 ( 4.0A);A80 A 201 ( 4.9A);A80 A 201 (-3.3A);None","0.49A","3cwkA-2cbrA:26.0","3cwkA-2cbrA:72.99"],["3DMF_A_SAMA388_0","PROBABLE RIBOSOMAL RNA SMALL SUBUNIT METHYLTRANSFERASE","3q3q","ALKALINE PHOSPHATASE","Sphingomonas sp. BSAR-1",5,"GLY A 492;ALA A  86;VAL A 476;PRO A 396;VAL A 366","GOL A8002 (-4.8A);GOL A8002 (-3.9A);None;None;None","1.06A","3dmfA-3q3qA:undetectable","3cwkA-2cbrA:72.99"],["3DMH_A_SAMA384_0","PROBABLE RIBOSOMAL RNA SMALL SUBUNIT METHYLTRANSFERASE","3q3q","ALKALINE PHOSPHATASE","Sphingomonas sp. BSAR-1",5,"GLY A 492;ALA A  86;VAL A 476;PRO A 396;VAL A 366","GOL A8002 (-4.8A);GOL A8002 (-3.9A);None;None;None","1.08A","3dmhA-3q3qA:undetectable","3dmfA-3q3qA:23.92"],["3P6G_A_IZPA133_1","FATTY ACID-BINDING PROTEIN, ADIPOCYTE","2cbr","PROTEIN (CRABP-I)","Bos taurus",5,"PHE A  15;PRO A  39;ARG A 111;ARG A 131;TYR A 133","None;A80 A 201 ( 4.9A);None;A80 A 201 (-3.8A);A80 A 201 (-4.7A)","0.66A","3p6gA-2cbrA:18.8","3dmhA-3q3qA:23.92"],["3P6G_A_IZPA133_1","FATTY ACID-BINDING PROTEIN, ADIPOCYTE","2cbr","PROTEIN (CRABP-I)","Bos taurus",5,"PHE A  15;PRO A  39;CYH A 129;ARG A 131;TYR A 133","None;A80 A 201 ( 4.9A);None;A80 A 201 (-3.8A);A80 A 201 (-4.7A)","1.40A","3p6gA-2cbrA:18.8","3p6gA-2cbrA:36.55"],["3QXT_B_MTXB2000_1","ANTI-METHOTREXATE CDR1-3 GRAFT VHH","1sjx","IMMUNOGLOBULIN VH DOMAIN","Lama glama",6,"VAL A 802;LEU A 804;MET A 834;VAL A 878;ALA A 897;TYR A 908","None;None;MPD A8001 ( 3.5A);None;None;None","0.87A","3qxtB-1sjxA:21.0","3p6gA-2cbrA:36.55"],["3TMZ_A_06XA503_1","CYTOCHROME P450 2B4","1rzm","PHOSPHO-2-DEHYDRO-3-DEOXYHEPTONATE ALDOLASE","Thermotoga maritima",5,"ILE A 233;ILE A 224;GLU A 164;PRO A 203;VAL A 162","None;None;PEP A8002 ( 4.8A);None;None","1.11A","3tmzA-1rzmA:undetectable","3qxtB-1sjxA:69.60"],["3V3N_A_MIYA2001_1","TETX2 PROTEIN","1sjx","IMMUNOGLOBULIN VH DOMAIN","Lama glama",5,"GLN A 911;MET A 834;GLY A 910;GLY A 826;ASN A 876","None;MPD A8001 ( 3.5A);None;None;None","1.39A","3v3nA-1sjxA:undetectable","3tmzA-1rzmA:21.41"],["3V3N_D_MIYD2001_1","TETX2 PROTEIN","1sjx","IMMUNOGLOBULIN VH DOMAIN","Lama glama",5,"GLN A 911;MET A 834;GLY A 910;GLY A 826;ASN A 876","None;MPD A8001 ( 3.5A);None;None;None","1.39A","3v3nD-1sjxA:undetectable","3v3nA-1sjxA:17.41"],["4A99_D_MIYD391_1","TETX2 PROTEIN","1sjx","IMMUNOGLOBULIN VH DOMAIN","Lama glama",5,"GLN A 911;MET A 834;GLY A 910;GLY A 826;ASN A 876","None;MPD A8001 ( 3.5A);None;None;None","1.42A","4a99D-1sjxA:undetectable","3v3nD-1sjxA:17.41"],["4AN2_A_EUIA1382_1","DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1","3dtc","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",6,"MET A 220;ASP A 268;LYS A 270;ASN A 273;GLY A 296;GLY A 311","VIN A6331 (-3.7A);SO4 A8001 ( 4.8A);SO4 A8001 (-3.0A);VIN A6331 ( 4.8A);None;None","0.97A","4an2A-3dtcA:25.9","4a99D-1sjxA:16.37"],["4CKJ_A_ADNA2014_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE RECEPTOR RET","3dtc","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",6,"GLY A 151;GLY A 153;VAL A 158;ALA A 169;ALA A 223;LEU A 275","VIN A6331 (-3.5A);SO4 A8001 ( 4.3A);VIN A6331 (-4.7A);VIN A6331 (-3.4A);VIN A6331 (-3.8A);VIN A6331 (-4.5A)","0.51A","4ckjA-3dtcA:26.8","4an2A-3dtcA:28.81"],["4DTZ_A_LDPA501_1","CYTOCHROME P450 BM3 VARIANT 8C8","3gbd","SUCROSE ISOMERASE SMUA FROM PROTAMINOBACTER RUBRUM","Serratia plymuthica",4,"PHE A 524;ALA A 364;LEU A 368;THR A 367","EDO A8008 ( 4.8A);None;None;None","0.98A","4dtzA-3gbdA:undetectable","4ckjA-3dtcA:33.13"],["4I41_A_MIXA500_1","SERINE\/THREONINE-PROTEIN KINASE PIM-1","3dtc","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",8,"PHE A 155;VAL A 158;ALA A 169;ILE A 204;ASP A 268;ASN A 273;LEU A 275;ASP A 294","VIN A6331 ( 2.9A);VIN A6331 (-4.7A);VIN A6331 (-3.4A);VIN A6331 ( 4.9A);SO4 A8001 ( 4.8A);VIN A6331 ( 4.8A);VIN A6331 (-4.5A);VIN A6331 (-4.0A)","0.86A","4i41A-3dtcA:22.0","4dtzA-3gbdA:21.37"],["4I41_A_MIXA500_1","SERINE\/THREONINE-PROTEIN KINASE PIM-1","3dtc","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",8,"PHE A 155;VAL A 158;ALA A 169;ILE A 204;ASP A 268;LYS A 270;ASN A 273;LEU A 275","VIN A6331 ( 2.9A);VIN A6331 (-4.7A);VIN A6331 (-3.4A);VIN A6331 ( 4.9A);SO4 A8001 ( 4.8A);SO4 A8001 (-3.0A);VIN A6331 ( 4.8A);VIN A6331 (-4.5A)","0.87A","4i41A-3dtcA:22.0","4i41A-3dtcA:28.34"],["4L9I_B_8PRB601_1","RHODOPSIN KINASE","3dtc","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",5,"GLY A 153;VAL A 158;ALA A 169;LYS A 171;MET A 220","SO4 A8001 ( 4.3A);VIN A6331 (-4.7A);VIN A6331 (-3.4A);None;VIN A6331 (-3.7A)","1.05A","4l9iB-3dtcA:19.7","4i41A-3dtcA:28.34"],["4L9I_B_8PRB601_1","RHODOPSIN KINASE","3dtc","MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 9","Homo sapiens",5,"GLY A 153;VAL A 158;ALA A 169;MET A 220;LEU A 275","SO4 A8001 ( 4.3A);VIN A6331 (-4.7A);VIN A6331 (-3.4A);VIN A6331 (-3.7A);VIN A6331 (-4.5A)","0.63A","4l9iB-3dtcA:19.7","4l9iB-3dtcA:22.70"],["4MJ8_A_SPMA202_1","SPERMIDINE N1-ACETYLTRANSFERASE","1d8c","MALATE SYNTHASE G","Escherichia coli",4,"ILE A 260;GLU A 239;GLN A 241;ILE A 242","SO4 A8000 (-3.9A);SO4 A8000 ( 4.7A);SO4 A8000 (-3.6A);None","0.79A","4mj8A-1d8cA:undetectable","4l9iB-3dtcA:22.70"],["4O8J_A_ADNA401_1","RNA 3'-TERMINAL PHOSPHATE CYCLASE","3fzy","RTX TOXIN RTXA","Vibrio cholerae",5,"GLN A3461;ARG A3513;GLN A3515;ASP A3606;HIS A3483","None;IHP A8000 (-2.6A);IHP A8000 ( 4.4A);None;IHP A8000 (-3.8A)","1.19A","4o8jA-3fzyA:0.0","4mj8A-1d8cA:12.31"],["4O8J_B_ADNB401_1","RNA 3'-TERMINAL PHOSPHATE CYCLASE","3fzy","RTX TOXIN RTXA","Vibrio cholerae",5,"GLN A3461;ARG A3513;GLN A3515;ASP A3606;HIS A3483","None;IHP A8000 (-2.6A);IHP A8000 ( 4.4A);None;IHP A8000 (-3.8A)","1.14A","4o8jB-3fzyA:0.1","4o8jA-3fzyA:20.50"],["4PEV_A_ADNA501_1","MEMBRANE LIPOPROTEIN FAMILY PROTEIN","3gbd","SUCROSE ISOMERASE SMUA FROM PROTAMINOBACTER RUBRUM","Serratia plymuthica",5,"VAL A 402;SER A 157;PHE A 159;ASP A  75;GLY A 160","None;None;None;EDO A8003 (-2.8A);EDO A8004 (-3.7A)","1.49A","4pevA-3gbdA:1.3","4o8jB-3fzyA:20.50"],["4QOI_A_ML1A303_1","RIBOSYLDIHYDRONICOTINAMIDE DEHYDROGENASE [QUINONE];RIBOSYLDIHYDRONICOTINAMIDE DEHYDROGENASE [QUINONE]","3gbd","SUCROSE ISOMERASE SMUA FROM PROTAMINOBACTER RUBRUM","Serratia plymuthica",4,"TYR A 240;PHE A 236;GLY A 160;ILE A 400","None;EDO A8004 (-4.8A);EDO A8004 (-3.7A);None","0.90A","4qoiA-3gbdA:undetectable;4qoiB-3gbdA:undetectable","4pevA-3gbdA:20.21"],["4QYN_A_RTLA201_0","RETINOL-BINDING PROTEIN 2","2cbr","PROTEIN (CRABP-I)","Bos taurus",5,"PHE A  15;ALA A  32;THR A  54;TRP A 109;LEU A 120","None;A80 A 201 ( 4.1A);A80 A 201 (-3.5A);None;None","0.75A","4qynA-2cbrA:20.1","4qoiA-3gbdA:16.08;4qoiB-3gbdA:16.08"],["4QZU_B_RTLB201_0","RETINOL-BINDING PROTEIN 2","2cbr","PROTEIN (CRABP-I)","Bos taurus",5,"PHE A  15;ALA A  32;THR A  54;TRP A 109;LEU A 120","None;A80 A 201 ( 4.1A);A80 A 201 (-3.5A);None;None","0.65A","4qzuB-2cbrA:20.3","4qynA-2cbrA:35.97"],["5B3S_P_CHDP306_0","CYTOCHROME C OXIDASE SUBUNIT 3","3l8m","PROBABLE THIAMINE PYROPHOSPHOKINASE","Staphylococcus saprophyticus",4,"LYS A 126;LEU A 127;PHE A 106;LEU A 110"," NA A8001 (-4.8A);None;None;None","0.82A","5b3sP-3l8mA:undetectable","4qzuB-2cbrA:35.97"],["5CSY_B_ACRB601_1","4-ALPHA-GLUCANOTRANSFERASE DPE1, CHLOROPLASTIC\/AMYLOPLASTIC","3gbd","SUCROSE ISOMERASE SMUA FROM PROTAMINOBACTER RUBRUM","Serratia plymuthica",5,"ARG A 212;ASP A 214;GLU A 268;HIS A 341;ASP A 342","None;EDO A8003 ( 2.7A);EDO A8001 (-3.1A);None;EDO A8002 ( 3.5A)","0.47A","5csyB-3gbdA:17.5","5b3sP-3l8mA:19.78"],["5H8T_A_RTLA201_0","RETINOL-BINDING PROTEIN 1","2cbr","PROTEIN (CRABP-I)","Bos taurus",5,"PHE A  15;LEU A  19;ALA A  32;ILE A  52;LEU A 120","None;None;A80 A 201 ( 4.1A);None;None","0.55A","5h8tA-2cbrA:19.8","5csyB-3gbdA:19.87"],["5VCY_A_DB8A401_2","MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2-INHIBITORY KINASE","3gbd","SUCROSE ISOMERASE SMUA FROM PROTAMINOBACTER RUBRUM","Serratia plymuthica",4,"VAL A 468;LEU A  58;ASN A 463;ASP A 439","EDO A8005 (-4.6A);None;None;None","1.35A","5vcyA-3gbdA:2.4","5h8tA-2cbrA:41.55"],["6AG0_A_ACRA610_0","ALPHA-AMYLASE","3gbd","SUCROSE ISOMERASE SMUA FROM PROTAMINOBACTER RUBRUM","Serratia plymuthica",5,"TYR A  78;HIS A 118;ASP A 214;HIS A 341;ASP A 342","EDO A8003 ( 4.4A);EDO A8003 (-4.8A);EDO A8003 ( 2.7A);None;EDO A8002 ( 3.5A)","0.42A","6ag0A-3gbdA:19.5","5vcyA-3gbdA:19.51"],["6B58_A_ACTA607_0","FUMARATE REDUCTASE FLAVOPROTEIN SUBUNIT","1rzm","PHOSPHO-2-DEHYDRO-3-DEOXYHEPTONATE ALDOLASE","Thermotoga maritima",4,"GLY A 274;ARG A 237;ASN A 248;LEU A 250","None;PEP A8002 (-3.9A);None;None","1.18A","6b58A-1rzmA:undetectable","6ag0A-3gbdA:11.43"],["6BPL_B_PA1B605_1","LIPID A EXPORT ATP-BINDING\/PERMEASE PROTEIN MSBA;LIPID A EXPORT ATP-BINDING\/PERMEASE PROTEIN MSBA","1rzm","PHOSPHO-2-DEHYDRO-3-DEOXYHEPTONATE ALDOLASE","Thermotoga maritima",3,"ARG A 247;ARG A 126;ARG A 133","None;PEP A8002 (-3.2A);E4P A8003 (-4.1A)","1.08A","6bplA-1rzmA:undetectable;6bplB-1rzmA:0.8","6b58A-1rzmA:23.59"],["6BPL_B_PA1B605_1","LIPID A EXPORT ATP-BINDING\/PERMEASE PROTEIN MSBA;LIPID A EXPORT ATP-BINDING\/PERMEASE PROTEIN MSBA","1rzm","PHOSPHO-2-DEHYDRO-3-DEOXYHEPTONATE ALDOLASE","Thermotoga maritima",3,"ARG A 247;ARG A 126;ARG A 237","None;PEP A8002 (-3.2A);PEP A8002 (-3.9A)","1.09A","6bplA-1rzmA:undetectable;6bplB-1rzmA:0.8","6bplA-1rzmA:16.85;6bplB-1rzmA:16.85"]]